RPS6KA3 and cancer: Similarly, mutations perturbing the ATP binding pocket of the RPS6KA3 kinase are associated to a significant increased risk in liver cancers (Cox, p = 8.65e−4; Table S5a) as well as cross-cancer (p = 3.71e−2; Table S5b,c).